Kiklin Sales Begin, Astellas And Sanwa Chemistry Work Together
22:00 EDT 27 Jun 2012 | Elsevier Business Intelligence
Astellas began sales of a hyperphosphatemia treatment drug Kiklin (generic: bixalomar) on June 26, for chronic renal failure patients undergoing dialysis.
Original Article: Kiklin Sales Begin, Astellas And Sanwa Chemistry Work Together
More From BioPortfolio on "Kiklin Sales Begin, Astellas And Sanwa Chemistry Work Together"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
